Oct. 12, 2017 | Led by UAMS researchers, a new clinical study called STAMPOUT aims to help a drug user stay in treatment by keeping the effects of the drug from going into the brain.

This month, the National Institutes of Health (NIH) National Institute on Drug Abuse awarded the InterveXion/UAMS research team an $8 million, three-year grant to fund STAMPOUT (Study of Antibody for Methamphetamine Outpatient Therapy). This will be the first clinical study in methamphetamine users of a medication developed specifically for patients who are meth users.